Is Celularity Stock a good buy in 2023, according to Wall Street analysts?
The consensus among 2 Wall Street analysts covering (NASDAQ: CELU) stock is to Sell CELU stock.
Out of 2 analysts, 0 (0%) are recommending CELU as a Strong Buy, 1 (50%) are recommending CELU as a Buy, 0 (0%) are recommending CELU as a Hold, 0 (0%) are recommending CELU as a Sell, and 1 (50%) are recommending CELU as a Strong Sell.
What is CELU's forecast return on equity (ROE) for 2023-2026?
(NASDAQ: CELU) forecast ROE is N/A, which is considered weak.
What is CELU's Price Target?
According to 2 Wall Street analysts that have issued a 1 year CELU price target, the average CELU price target is $1.75, with the highest CELU stock price forecast at $2.50 and the lowest CELU stock price forecast at $1.00.
On average, Wall Street analysts predict that Celularity's share price could reach $1.75 by Jan 30, 2024. The average Celularity stock price prediction forecasts a potential upside of 167.58% from the current CELU share price of $0.65.
What is CELU's forecast return on assets (ROA) for 2023-2026?
(NASDAQ: CELU) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 0.09%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.